YIA 2025 Recipient
MOASC Cary Presant Young Investigator Award
The 2025 Award recipient is Peter Zang, MD, Fellow in Hematology & Medical Oncology at the renowned City of Hope National Medical Center, for his ground breaking research in Metastatic Castrate Resistant Prostate Cancer (mCRPC), a challenging and aggressive form of prostate cancer. His innovative work focuses on improving treatment strategies and advancing the understanding of this complex disease, which remains one of the leading causes of cancer-related deaths among men worldwide. To learn more Dr. Zang's Research, visit: https://youtu.be/VAjuwC1C5gY?si=POJjgJtS3SL5Uzy1
.
"We are thrilled to honor Dr. Zang with the 2025 Cary Presant, MD Young Investigator Award," said Dr. Lashkari, "His dedication to advancing our understanding of metastatic prostate cancer is exemplary, and his research holds the potential to significantly improve outcomes for patients battling this devastating disease."
.
.
